Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
1
x
$
30.00
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
1
x
$
30.00
Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study
1
x
$
30.00
Treatment of Children with Attention-Deficit/Hyperactivity Disorder: Results of a Randomized, Multicenter, Double-Blind, Crossover Study of Extended-Release Dexmethylphenidate and D,L-Methylphenidate and Placebo in a Laboratory Classroom Setting
1
x
$
30.00
Thomas E. Gillen, MD, MS: Clinical Trials in Alzheimer’s Disease
1
x
$
30.00
Epidural Blood Patch does not Contribute to the Development of Chronic Low Back Pain in Patients who Undergo Lumbar Punctures: A Pilot Study
1
x
$
30.00
Douglas G. Kondo, MD: An Evidence-Based Medicine Approach to Combined Treatment for ADHD in Children and Adolescents
1
x
$
30.00
Neuropharmacology of Paroxetine
1
x
$
30.00
View Cart
Checkout
Home
paul-j-perry
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Paul J. Perry, PhD: Therapeutic Drug Monitoring of Antipsychotics
$
30.00
Add to cart
Details
Ryan M. Carnahan, PharmD: A Critical Appraisal of the Utility of the Serum Anticholinergic Activity Assay in Research and Clinical Practice
$
30.00
Add to cart
Details
Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Page load link
Go to Top
